Canadian Genomics R&D Initiative on AMR One Health -- Experimental Genome sequencing and assembly. Canadian Genomics R&D Initiative on AMR One Health -- Experimental

Resistance to antimicrobial medicines (antimicrobial resistance, AMR) is an important public health challenge. In particular, the development of resistance to antimicrobials by bacterial and fungal pathogens that were formerly sensitive poses a great threat to human and animal health. The GRDI AMR project maps the development and transit of AMR through healthcare, animals, plants, wastewater and the environment. https://grdi.canada.ca/en. This project includes genomic analyses following experimental interventions (e.g. Conjugation, passaging, feeding studies).